Sino Biopharmaceutical Limited (1177.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 100.21B |
| Enterprise Value | 108.9B |
| P/E Ratio | 33.22 |
| PEG Ratio | 1.11 |
| Price/Sales Ratio | 2.42 |
| Price/Book Ratio | 2.54 |
| Enterprise/Revenue | 2.69 |
| Enterprise/EBITDA | 11.82 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | 0.22 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.07 |
Income Statement
| Revenue | 31.83B |
| Revenue/Share | 1.77 |
| Gross Profit | 26.13B |
| EBITDA | 7.26B |
| Net Income | 2.34B |
| Diluted EPS | 0.13 |
Balance Sheet
| Total Cash | 22.56B |
| Total Cash/Share | 1.25 |
| Total Debt | 16.07B |
| Total Debt/Equity | 0.52 |
| Current Ratio | 1.37 |
| Book Value Per Share | 2.37 |
Price History
| 52-Week Change | -31.28 |
| 52-Week High | 9.12 |
| 52-Week Low | 4.19 |
| Moving Average 50 Days | 4.86 |
| Moving Average 200 Days | 6.01 |
Statistics
| Average Volume | 96.15M |
| Shares Outstanding | 17.81B |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.09 |
| Trailing Annual Dividend Yield | 1.99 |
| Payout Ratio | 0.64 |
| Last Split Factor | 3:2 |
| Last Split Date | July 20, 2020 |
AD
